6Hirsh J, Warkentin TE, Shaughnessy SG, et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics dosing, monitoring, efficacy, and safety[J]. Chest,2001,119(1 suppl): 64.
7Quartermain D, Yongsheng Li, Jonas S. Enoxaparin. a low molecular weight heparin decreases infarct size and improves sensorimotor function in a rat model of focal cerebral ischemia[J]. Neuroscience Letters,2000,288(2) : 155.
8Holmer E. Low molecular weight heparin[A]. In:Lane DA & Lindahl U,eds. Heparin[C].London:EdwardAmold,1989.575～590.
9Hirsh J. Low molecular weight heparin[J].Blood,1992,79(1):1.
10George A,Neville F,Thomas J,et al.Clinical composition,particle size range,and biochemical activity of some low molecular weight heparin derivatives[J].J Pharm Sci,1990,79(4):339.
4Liu-Shun Feng, Ke Li, Qi-Ping Peng, Xiu-Xian Ma, Yong-Fu Zhao, Pei-Qin Xu and Xiao-Ping Chen Zhengzhou, China Department of General Surgery, First Affiliated Hospi- tal , Zhengzhou University, Zhengzhou 450052 , China ,Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.Triplex operation for portal hypertension with esophageal variceal bleeding:report of 140 cases[J].Hepatobiliary & Pancreatic Diseases International,2004,3(4):534-537. 被引量：9
